Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Larson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer|September 17, 2014
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AMLJorge E Cortes, Stuart L Goldberg, Eric J Feldman, et al.
Translational Oncology|April 26, 2022
Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumorsMax J Cotler, Khalil B Ramadi, Xiaonan Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitmentPratik Home, Biswarup Saha, Soma Ray, et al.
Leukemia & Lymphoma|November 3, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort studyNadia Toumeh, Melissa Larson, Brianna Negaard, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemiaSusan O'Brien, Gary Schiller, John Lister, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer|September 17, 2014
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AMLJorge E Cortes, Stuart L Goldberg, Eric J Feldman, et al.
Translational Oncology|April 26, 2022
Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumorsMax J Cotler, Khalil B Ramadi, Xiaonan Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitmentPratik Home, Biswarup Saha, Soma Ray, et al.
Leukemia & Lymphoma|November 3, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort studyNadia Toumeh, Melissa Larson, Brianna Negaard, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemiaSusan O'Brien, Gary Schiller, John Lister, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Pageof 2